A. B. BOZ ER And İ. ER, "Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer," International Journal of Molecular Sciences , vol.25, no.16, 2024
BOZ ER, A. B. And ER, İ. 2024. Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer. International Journal of Molecular Sciences , vol.25, no.16 .
BOZ ER, A. B., & ER, İ., (2024). Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer. International Journal of Molecular Sciences , vol.25, no.16.
BOZ ER, ASİYE, And İDRİS ER. "Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer," International Journal of Molecular Sciences , vol.25, no.16, 2024
BOZ ER, ASİYE B. And ER, İDRİS. "Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer." International Journal of Molecular Sciences , vol.25, no.16, 2024
BOZ ER, A. B. And ER, İ. (2024) . "Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer." International Journal of Molecular Sciences , vol.25, no.16.
@article{article, author={ASİYE BÜŞRA BOZ ER And author={İDRİS ER}, title={Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer}, journal={International Journal of Molecular Sciences}, year=2024}